Keith Michael Gottesdiener - Oct 8, 2024 Form 4 Insider Report for Prime Medicine, Inc. (PRME)

Role
President and Chief Executive Officer, Director
Signature
/s/ Karen Brown, attorney-in-fact
Stock symbol
PRME
Transactions as of
Oct 8, 2024
Transactions value $
$0
Form type
4
Date filed
10/10/2024, 04:29 PM
Previous filing
Jun 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRME Common Stock Gift $0 -227K -81.87% $0.00 50.2K Oct 8, 2024 By Spouse F1
transaction PRME Common Stock Gift $0 +227K +49.84% $0.00 682K Oct 8, 2024 By Trust F1, F2
holding PRME Common Stock 2.31M Oct 8, 2024 Direct
holding PRME Common Stock 1.32M Oct 8, 2024 By Trust F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On October 8, 2024, for bona fide estate planning purposes, the Reporting Person's spouse transferred 226,925 shares of Issuer common stock to a family trust for no consideration.
F2 Shares held by a trust for which certain of the Reporting Person's family member is a trustee. The Reporting Person disclaims beneficial ownership except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.
F3 Shares held by a trust for which the Reporting Person's spouse and certain of the Reporting Person's family member are co-trustees. The Reporting Person disclaims beneficial ownership except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.

Remarks:

President and Chief Executive Officer